Old names:
Owner | Filings | Transaction Date | Type of Owner |
---|---|---|---|
HAUSMAN DIANA | 0001563992 | May-08-2023 | director |
Roth Iris | 0001964808 | Feb-13-2023 | officer: Chief Operating Officer |
Brownstein Carrie | 0001894232 | Oct-03-2022 | officer: Chief Medical Officer |
Skvarka Jan | 0001838042 | Sep-09-2022 | director |
Paul Andrea | 0001863130 | Aug-01-2022 | officer: General Counsel |
Kariuki Enoch | 0001843119 | Feb-09-2021 | director |
Pinto Alexis | 0001819302 | Aug-31-2020 | officer: Chief Legal Officer |
Blackwell Kimberly | 0001816465 | Jul-01-2020 | director |
VIKING GLOBAL INVESTORS LP | 0001103804 | Apr-03-2020 | 10 percent owner |
HALVORSEN OLE ANDREAS | 0001133006 | Apr-03-2020 | 10 percent owner |
SUN ANTHONY Y | 0001377952 | Apr-03-2020 | director, officer: President & CEO |
Matrix Capital Management Company, LP | 0001410830 | Apr-03-2020 | director, 10 percent owner, other: See Remarks |
GOEL DAVID E. | 0001548144 | Apr-03-2020 | director, 10 percent owner |
Gallagher Cam | 0001557832 | Apr-03-2020 | director |
Ott David C. | 0001621842 | Apr-03-2020 | 10 percent owner |
Viking Global Opportunities Portfolio GP LLC | 0001629472 | Apr-03-2020 | 10 percent owner |
Viking Global Opportunities GP LLC | 0001629476 | Apr-03-2020 | 10 percent owner |
Viking Global Opportunities Illiquid Investments Sub-Master LP | 0001629482 | Apr-03-2020 | 10 percent owner |
Shabet Rose Sharon | 0001711393 | Apr-03-2020 | 10 percent owner |
Epperly Melissa B, | 0001807359 | Apr-03-2020 | officer: Chief Financial Officer |
Takhar Karan S. | 0001807398 | Apr-03-2020 | director |
Bunker Kevin D. | 0001807484 | Apr-03-2020 | officer: Chief Operating Officer |
Voliotis Dimitris | 0001807910 | Apr-03-2020 | officer: SVP, Clinical Development |
Recurium Equity, LLC | 0001808095 | Apr-03-2020 | 10 percent owner |
Johnson David Michael | 0001808098 | Apr-03-2020 | director |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Zentalis Pharmaceuticals, Inc.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
S-8 | Document | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0001628280-24-008062 (33 Act) Size: 368 KB |
Feb-29-2024 | 24705180 |
S-3ASR | Document | Automatic shelf registration statement of securities of well-known seasoned issuers Acc-no: 0001628280-24-008056 (33 Act) Size: 1399 KB |
Feb-29-2024 | 24705089 |
10-K | Document | Annual report pursuant to section 13 and 15(d) Acc-no: 0001725160-24-000080 (34 Act) Size: 48464 KB |
Feb-27-2024 | 24681940 |
8-K | Document | Current report filing Acc-no: 0001725160-24-000079 (34 Act) Size: 354 KB |
Feb-27-2024 | 24681923 |
8-K | Document | Current report filing Acc-no: 0001725160-24-000057 (34 Act) Size: 516 KB |
Feb-15-2024 | 24643942 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001104659-24-023930 (34 Act) Size: 134 KB |
Feb-14-2024 | 24639965 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000919574-24-001194 (34 Act) Size: 158 KB |
Feb-13-2024 | 24631207 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001104659-24-022352 (34 Act) Size: 12 KB |
Feb-13-2024 | 24629970 |
144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001725160-24-000049 (33 Act) Size: 5 KB |
Feb-12-2024 | 24622206 |
144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001725160-24-000047 (33 Act) Size: 5 KB |
Feb-12-2024 | 24622205 |
144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001725160-24-000045 (33 Act) Size: 5 KB |
Feb-12-2024 | 24622203 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001725160-24-000043 ( Act) Size: 5 KB |
Feb-12-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001725160-24-000041 ( Act) Size: 5 KB |
Feb-12-2024 | |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001422848-24-000149 (34 Act) Size: 18 KB |
Feb-09-2024 | 24616631 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000315066-24-001568 (34 Act) Size: 8 KB |
Feb-09-2024 | 24612622 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000902219-24-000276 (34 Act) Size: 32 KB |
Feb-09-2024 | 24611404 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001725160-24-000036 ( Act) Size: 7 KB |
Feb-05-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001725160-24-000034 ( Act) Size: 9 KB |
Feb-05-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001725160-24-000032 ( Act) Size: 11 KB |
Feb-05-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001725160-24-000030 ( Act) Size: 9 KB |
Feb-05-2024 |
Recent 20 filings. View all Zentalis Pharmaceuticals, Inc. filings
Thanks I look forward to using the product to improve my skin tone
young lad who new his job ansered questions and new what was best for me.
It's being easier working on the website. And I recommend, it's a great website
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by